Preclinical development of a stathmin-2 splicing modulator for ALS
Ended Project Grant Awarded Last action
- Award ID
- R44NS120604
- Recipient
-
Quralis Corporation UEI ZHB4WDW8MB37
- Awarding agency
-
National Institute of Neurological Disorders and Stroke
National Institutes of Health, Department of Health and Human Services
- Obligated
- $0
Award facts
- Assistance listing
- 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders
- Completion date
- Place of performance
- Cambridge, MA 02139, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$499,987 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $499,987 |
Quick answers
Who received award R44NS120604?
R44NS120604 was awarded to Quralis Corporation by National Institute of Neurological Disorders and Stroke (National Institutes of Health) on September 30, 2020.
How much is award R44NS120604 worth?
$0 has been obligated on R44NS120604.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award